1. USD

    62.32

    Today's change

    0.29 / +0.47%

    1 year change

    +18.80%

    As of Aug 22 2014 21:00 BST. Data delayed by at least 15 minutes.

Search for Eli Lilly & Co and
  1. July 16, 2014

    Eli Lilly joins forces with UK biotech to develop cancer drugs

    Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill cancer...

  2. June 12, 2014

    Taxing time ahead as offshore rules come under more scrutiny

    ‘Golden age’ for offshore cash The OECD called it “the golden age” of tax planning: a period in which multinational...

Special Reports

  1. Special Report: Boldness in Business 2012

    Seven success stories are honoured in this year’s awards...
  2. Combating Diabetes

    With the number of cases predicted to reach 592m worldwide by 2013, tackling the condi...
Search more Special Reports on this topic.

  1. June 8, 2014

    Japanese drugmakers sit out global M&A party

    Japanese drugmakers have been conspicuous by their absence from the dealmaking bonanza sweeping the sector across Europe and...

  2. May 7, 2014

    Pharma and Pfizer’s reputations on the line

    The proportion of UK cancer patients who survive 10 years after diagnosis rose from 25 per cent in the 1970s to 50 per cent...

  3. April 22, 2014

    Eli Lilly: animal spirits

    Eli Lilly has nothing if not momentum. Over six months, the drugmaker’s shares have returned 23 per cent, among the best of...

  4. April 22, 2014

    Eli Lilly: momentum and mean reversion

    Eli Lilly The investment universe has a Zoroastrian structure. The battle is between momentum and mean reversion. Stocks...

  5. April 22, 2014

    Novartis buys GSK business for up to $16bn in restructuring

    Novartis and GlaxoSmithKline have agreed to swap a series of assets in a multibillion-dollar deal that will reshape two of...

  6. April 11, 2014

    Big pharma: Storehouse of trouble

    Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and hosts...

  7. April 8, 2014

    Takeda and Eli Lilly fall foul of  jury in Actos trial

    For Mark Lanier, it was the biggest victory of his career as a plaintiff’s lawyer: a $9bn award for punitive damages against...

  8. April 8, 2014

    Takeda: a fine mess

    It’s a big, scary number. A US court has hit the Japanese drug company Takeda with a $6bn penalty after finding that it...

  9. FT Alphaville

    April 8, 2014

    The (early) Lunch Wrap

    Good morning New York, FT ALPHAVILLE David revisits the €1,000,000,000,000 question, what will the ECB do? Dan notes the...

  10. April 8, 2014

    Takeda ordered to pay record $6bn over diabetes drug claim

    A US jury has hit two drug companies with a record $9bn fine for hiding an alleged link between a best-selling diabetes...

  11. February 19, 2014

    Eli Lilly jumps after cancer drug trial

    Shares in Eli Lilly climbed after the US pharmaceuticals group said a study of a lung cancer treatment increased survival...

  12. December 26, 2013

    Ethics: End of the hard sell?

    When Johnson & Johnson wanted to boost prescriptions of Natrecor, a heart medicine, it channelled more than $100,000 through...

  13. November 14, 2013

    Drug manufacturers seek to expand the range of treatments

    Three companies have long dominated the commercial battle over insulin. For nearly a century since it was first developed,...

  14. October 28, 2013

    Merck falls after miss on revenue

    Merck shares moved lower but the S&P500 touched another record high as company earnings were in focus. The health and...

  15. September 26, 2013

    Multinationals beach tax bills in Spanish shells

    A rented office overlooking a dusty rail track near Madrid’s airport was until recently the workplace of what would appear...

  16. September 26, 2013

    JC Penney rebounds on progress report

    JC Penney shares rebounded after a sharp slide in premarket trading, after the company said it was pleased with the progress...

  17. September 23, 2013

    Bribery claims infect drug companies’ dealings in China

    It began as a rumour on a Chinese social media site in July, but the impact has swiftly spread around the world: allegations...

  18. August 22, 2013

    Eli Lilly drawn into pharmaceutical corruption claims in China

    Eli Lilly became the latest western pharmaceutical group to be drawn into escalating allegations of corruption in China,...

  19. August 13, 2013

    Yum Brands hit by poor Chinese sales

    US markets continued a slow downward trend as Yum Brands fell on new sales data that showed its Chinese business continued...

  20. July 28, 2013

    Ireland’s ‘patent cliff’ poses problems for exit of bailout

    The metal reactors at Pfizer’s 200-acre manufacturing plant in Ringaskiddy that make the drug Viagra are not as busy as they...

  21. July 24, 2013

    China’s claims against GlaxoSmithKline echo SEC actions

    The allegations that Chinese authorities have made against GlaxoSmithKline’s operations resemble those levelled at other...

  22. July 24, 2013

    Apple rises above mixed US markets

    Well-received earnings from Apple boosted shares in the iPhone maker, helping the Nasdaq to post a slight increase while the...

  23. July 18, 2013

    Belgian pharma group in China probe

    UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing...

  24. June 25, 2013

    Eisai to pull epilepsy drug from Germany

    Eisai, the Japanese pharmaceutical group, is to stop selling its new epilepsy drug in Germany over concerns that the...

  25. May 29, 2013

    Smithfield rises as S&P 500 heads lower

    US stocks stumbled on Wednesday as nine of the ten S&P 500 sectors finished lower, with Smithfield Foods standing out after...

  26. May 22, 2013

    US doctors paid $1bn by top drug companies

    A dozen leading drug companies paid US doctors a total of more than $1bn last year, according to fresh data revealing the...

  27. May 1, 2013

    Novo Nordisk/Lundbeck: drugs start working

    The news from Denmark’s sizeable pharmaceuticals sector has been suitably Nordic noir recently. H Lundbeck, beset by patent...

  28. April 29, 2013

    US pharma: spot the difference

    The big US drug companies look eerily alike. Pfizer, Merck, Eli Lilly and AbbVie (formerly Abbott) are all expanding...

  29. April 4, 2013

    Healthcare: Big pharma, big data

    When Guido Rasi took charge of Europe’s medicines’ regulator in 2011 he inherited an explosive dossier that is now poised to...

  30. March 26, 2013

    Science: Custodians of the code

    Joanna Hershey’s gut told her the news would be bad when she decided to undergo genetic testing to see if she was at high...

  31. February 25, 2013

    Genus plans further China expansion

    Genus, the animal genetics group, has stepped up its expansion into China, outlining plans to open a raft of joint ventures...

  32. February 11, 2013

    Novo Nordisk: reality check

    There goes the visibility premium. Novo Nordisk has stood out from rivals in recent years because its growth has been so...

  33. February 11, 2013

    FDA rejects Novo Nordisk insulin remedy

    Novo Nordisk lost DKr80bn from its stock market value after the Danish drugs company failed to win US regulatory approval...

  34. January 29, 2013

    Pfizer hints core drugs unit may be split

    Pfizer, on the heels of shedding its infant nutrition and animal health units, signalled on Tuesday that it might eventually...

  35. December 20, 2012

    Eli Lilly settles bribery charges

    Eli Lilly, the US pharmaceutical company, has agreed to pay $30m to settle charges that it engaged in a scheme to bribe...

  36. November 18, 2012

    Novo Nordisk becomes largest Nordic group

    Novo Nordisk has become the largest company in the Nordic region by market capitalisation, overtaking Norway’s Statoil,...

  37. October 15, 2012

    US equities boosted by retail data

    Citigroup shares gained as the US bank beat market expectations for the third quarter, despite reporting an 88 per cent fall...

  38. September 19, 2012

    US healthcare groups braced for budget cuts

    US healthcare companies are bracing for the consequences of automatic budget cuts next year that could take away billions of...

Search for Eli Lilly & Co and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Eli Lilly's John Lechleiter says pharma must reach out to inn...
    June 15, 2012

    Eli Lilly's John Lechleiter says pharma must reach out ...